Telix Pharmaceuticals Limited - American Depositary Shares (NQ:TLX)
9.879
-0.181
(-1.80%)
Streaming Delayed Price
Updated: 10:51 AM EDT, Jul 31, 2026
Add to My Watchlist
Price and Volume
Detailed Quote| Volume | 20,249 |
| Open | 10.00 |
| Bid (Size) | 9.860 (600) |
| Ask (Size) | 9.890 (600) |
| Prev. Close | 10.06 |
| Today's Range | 9.790 - 10.01 |
| 52wk Range | 6.280 - 14.27 |
| Shares Outstanding | N/A |
| Dividend Yield | N/A |
Top News
More News
Telix H1 2026 Results: Investor Webcast Notification
July 30, 2026
Performance
More News
Read More
FDA Alignment to Advance ProstACT Global Phase 3 Trial
July 01, 2026
TLX101-Px (Pixlumi®) MAA Accepted in Europe
April 30, 2026
FDA Accepts NDA for TLX101-Px (Pixclara®)
April 09, 2026
Telix Appoints David Gill as Non-Executive Director
April 01, 2026
Frequently Asked Questions
Is Telix Pharmaceuticals Limited - American Depositary Shares publicly traded?
Yes, Telix Pharmaceuticals Limited - American Depositary Shares is publicly traded.
What exchange does Telix Pharmaceuticals Limited - American Depositary Shares trade on?
Telix Pharmaceuticals Limited - American Depositary Shares trades on the Nasdaq Stock Market
What is the ticker symbol for Telix Pharmaceuticals Limited - American Depositary Shares?
The ticker symbol for Telix Pharmaceuticals Limited - American Depositary Shares is TLX on the Nasdaq Stock Market
What is the current price of Telix Pharmaceuticals Limited - American Depositary Shares?
The current price of Telix Pharmaceuticals Limited - American Depositary Shares is 9.879
When was Telix Pharmaceuticals Limited - American Depositary Shares last traded?
The last trade of Telix Pharmaceuticals Limited - American Depositary Shares was at 07/31/26 10:51 AM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.